Publications by authors named "O Gayet"

Claim this Profile
T
The T-Box Transcription Factors TBX2 and TBX3 Are Molecular Targets of Piroctone Olamine in the Treatment of Pancreatic Cancer.
Karabo Serala, Sanele Mdletshe, Jinming Bai, Amaal Abrahams, Odile Gayet

J Cell Mol Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers.
Abdessamad El Kaoutari, Nicolas A Fraunhoffer, Stéphane Audebert, Luc Camoin, Yolande Berthois, Odile Gayet

EBioMedicine· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining the antianginal drug perhexiline with chemotherapy induces complete pancreatic cancer regression .
Gabriela Reyes-Castellanos, Nadine Abdel Hadi, Scarlett Gallardo-Arriaga, Rawand Masoud, Julie Garcia, Odile Gayet

iScience· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity.
Nicolas Alejandro Fraunhoffer, Analía Meilerman Abuelafia, Brice Chanez, Martin Bigonnet, Odile Gayet

Cancer Commun (Lond)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction.
Nicolas A Fraunhoffer, Analía Meilerman Abuelafia, Martin Bigonnet, Odile Gayet, Julie Roques

NPJ Precis Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis